ATS 2018 International Conference - Mobile

B103 - ILD: MANAGEMENT

Location: 6D

Session Type: RAPiD: Rapid Abstract Poster Discussion Session

Monday

May

21

2:15 PM

4:15 PM

Presentation(s)

Physician Characteristics Associated with Treatment Initiation Patterns in Idiopathic Pulm...
05-21-2018 2:15 PM - 4:15 PM
Understanding the Informational Needs of Idiopathic Pulmonary Fibrosis (IPF) Patients and ...
05-21-2018 2:15 PM - 4:15 PM
Effects of Supplemental Oxygen Therapy in Patients with Pulmonary Fibrosis [Board No. 212]
05-21-2018 2:15 PM - 4:15 PM
Anti-Fibrotic Therapy and Patient Reported Outcomes in Idiopathic Pulmonary Fibrosis [Boar...
05-21-2018 2:15 PM - 4:15 PM
Real World Experience of Pirfenidone and Nintedanib for the Treatment of Idiopathic Pulmon...
05-21-2018 2:15 PM - 4:15 PM
Pattern of Utilization for Antifibrotic Therapy in Idiopathic Pulmonary Fibrosis [Board No...
05-21-2018 2:15 PM - 4:15 PM
Safety, Tolerability and Efficacy of Nintedanib Switched from Pirfenidone in Patients with...
05-21-2018 2:15 PM - 4:15 PM
The Effect of Inhaled Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) for Patien...
05-21-2018 2:15 PM - 4:15 PM
Gender and BMI Predict Antifibrotic Tolerance in IPF [Board No. 208]
05-21-2018 2:15 PM - 4:15 PM
Outcomes of Antifibrotic Treatment in Idiopathic Pulmonary Fibrosis (IPF) Patients with Ci...
05-21-2018 2:15 PM - 4:15 PM
Treatment Recommendations for Sarcoidosis: Results of a Delphi Consensus Study [Board No. ...
05-21-2018 2:15 PM - 4:15 PM
Longitudinal Changes in Quality of Life in Patients with Idiopathic Pulmonary Fibrosis Tre...
05-21-2018 2:15 PM - 4:15 PM
Educational Needs in Idiopathic Pulmonary Fibrosis for Healthcare Providers, Patients, and...
05-21-2018 2:15 PM - 4:15 PM
Current Treatment of Patients with Non-IPF Progressive Fibrosing Interstitial Lung Disease...
05-21-2018 2:15 PM - 4:15 PM
An Analysis of the Effectiveness of the Palliative Care-Psychology-ILD Multidisciplinary M...
05-21-2018 2:15 PM - 4:15 PM
Use of Steroids Prior to Hospitalization in Interstitial Lung Disease Patients Admitted wi...
05-21-2018 2:15 PM - 4:15 PM
Effect of Nintedanib on Exercise Capacity in Patients with Idiopathic Pulmonary Fibrosis (...
05-21-2018 2:15 PM - 4:15 PM
The Impact of Carrying Supplemental Oxygen on Physiologic and Patient-Centered Outcomes in...
05-21-2018 2:15 PM - 4:15 PM
Automatic Oxygen Titration Improves Exercise Tolerance in Patients with Idiopathic Lung Fi...
05-21-2018 2:15 PM - 4:15 PM
Lung Function Response and Changes of Lung Cysts to Rapamycin for Lymphangioleiomyomatosis...
05-21-2018 2:15 PM - 4:15 PM
Saint George’s Respiratory Questionnaire (SGRQ) Results in the PRAISE Trial in Idiopathic ...
05-21-2018 2:15 PM - 4:15 PM
Impact of Antacid Therapy on Transplant Free Survival of Patients with Idiopathic Pulmonar...
05-21-2018 2:15 PM - 4:15 PM
Medication Persistence Rates and Factors of Anti-Fibrotic Agents for Idiopathic Pulmonary ...
05-21-2018 2:15 PM - 4:15 PM
Safety of Combined Pirfenidone and Nintedanib in Subgroups of Patients with Idiopathic Pul...
05-21-2018 2:15 PM - 4:15 PM
Moderator
05-21-2018 2:15 PM - 4:15 PM
Moderator
05-21-2018 2:15 PM - 4:15 PM
Moderator
05-21-2018 2:15 PM - 4:15 PM